Kensei Tobinai
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 10, 2024
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi
|Jul 02, 2020
Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma.Shinichi Makita, Dai Maruyama, Kensei Tobinai
|Jul 01, 2017
Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma.Suguru Fukuhara, Junko Nomoto, Sung-Won Kim
|Dec 23, 2016
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies.Kensei Tobinai, Christian Klein, Naoko Oya
|Oct 06, 2015
Integrated molecular analysis of adult T cell leukemia/lymphoma.Keisuke Kataoka, Yasunobu Nagata, Akira Kitanaka
Pageof 1
Frequent Collaborators
2 joint publications
Dai Maruyama
1 joint publications
Ryohei Ishii
1 joint publications
Akifumi Takaori-Kondo
1 joint publications
Masao Matsuoka
1 joint publications
Yukio Kobayashi
1 joint publications
Shinichi Makita
1 joint publications
Takashi Watanabe
1 joint publications
Kazuyuki Shimada
1 joint publications
Michinori Ogura
1 joint publications
Junya Kuroda
